FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134788313> ?p ?o ?g. }

• W3134788313 endingPage "111683" @default.
• W3134788313 startingPage "111683" @default.
• W3134788313 abstract "Exemestane (EXE), a drug used for the treatment of breast cancer, has limited aqueous solubility of 0.08 mg/mL and log P∼ 4.22. The only available marketed formulation in form of tablets possess limitations of poor oral absorption (∼ 42 %), low solubility, extensive hepatic metabolism and numerous adverse effects due to its peripheral absorption. In order to address these issues, an alternative route of topical application is attempted through a lamellar liquid crystal based formulation. Pluronic® was used as stabilizer due to its higher surface activity and gelling properties. The solubility enhancement of EXE was achieved using liquid crystal formulation. We have investigated the effect of concentration of oil, Smix (surfactant – cosurfactant mixture) and EXE on lattice parameter, rheology and drug release for various combinations of the formulation. The small angle x-ray scattering (SAXS) measurement demonstrated an evidence of a lamellar structure with lattice parameter ∼15 nm, which increases with corresponding increase in oil and EXE due to increase in hydrophobic interactions leading to an expansion of lamella. The inter lamellar distance decreases at higher surfactant concentration, due to the distribution of the same amount of oil and drug within larger concentration of surfactant molecules. The rheology measurement exhibited gel like properties at low shear rate indicating soft gel formation, which converts to Newtonian type flowing liquid at higher shear rate. At constant Smix with increasing oil content, the viscosity decreases, which is attributed to the dilution of the lamellar structures with oil. The temperature sweep rheology reveals a change in the viscosity near physiological temperature, which may be attributed to the structural transition of lamellae. The formulation remains gel like at room temperature, which aids in proper application to skin and converts it to free flowing liquid above 37 °C. The invitro drug release of optimized formulation for 24 h was ∼ 38 % at 37 °C, which increased to 50 % at 42 °C. Accordingly, this formulation containing thermoresponsive lamellar liquid crystal gels of EXE represents a viable option for hyperthermia induced enhanced drug release. The characteristic and advantageous features offered by this formulation includes improved bioavailability of EXE due to enhanced solubility, permeability and absorption." @default.
• W3134788313 created "2021-03-15" @default.
• W3134788313 creator A5001164727 @default.
• W3134788313 creator A5016650663 @default.
• W3134788313 creator A5025782324 @default.
• W3134788313 creator A5032146345 @default.
• W3134788313 creator A5050082956 @default.
• W3134788313 creator A5074061540 @default.
• W3134788313 creator A5082976369 @default.
• W3134788313 creator A5085767473 @default.
• W3134788313 creator A5086999571 @default.
• W3134788313 date "2021-06-01" @default.
• W3134788313 modified "2023-10-14" @default.
• W3134788313 title "Thermoresponsive liquid crystalline formulation of Exemestane: Design and structural characterization" @default.
• W3134788313 cites W1967268541 @default.
• W3134788313 cites W1977714450 @default.
• W3134788313 cites W1978521258 @default.
• W3134788313 cites W1980928711 @default.
• W3134788313 cites W1981699359 @default.
• W3134788313 cites W1989512004 @default.
• W3134788313 cites W1989691557 @default.
• W3134788313 cites W2008580025 @default.
• W3134788313 cites W2012468775 @default.
• W3134788313 cites W2016248311 @default.
• W3134788313 cites W2020065192 @default.
• W3134788313 cites W2020102929 @default.
• W3134788313 cites W2036325346 @default.
• W3134788313 cites W2037602102 @default.
• W3134788313 cites W2039890880 @default.
• W3134788313 cites W2044416746 @default.
• W3134788313 cites W2050005850 @default.
• W3134788313 cites W2052502786 @default.
• W3134788313 cites W2053621027 @default.
• W3134788313 cites W2055268089 @default.
• W3134788313 cites W2061232589 @default.
• W3134788313 cites W2061546525 @default.
• W3134788313 cites W2072761272 @default.
• W3134788313 cites W2077863217 @default.
• W3134788313 cites W2080040110 @default.
• W3134788313 cites W2083718919 @default.
• W3134788313 cites W2088904910 @default.
• W3134788313 cites W2089401957 @default.
• W3134788313 cites W2092196207 @default.
• W3134788313 cites W2122360910 @default.
• W3134788313 cites W2346871046 @default.
• W3134788313 cites W2404938285 @default.
• W3134788313 cites W2606806481 @default.
• W3134788313 cites W2615011733 @default.
• W3134788313 cites W2734285335 @default.
• W3134788313 cites W2735613019 @default.
• W3134788313 cites W2749925396 @default.
• W3134788313 cites W2758217935 @default.
• W3134788313 cites W2765683660 @default.
• W3134788313 cites W2944535138 @default.
• W3134788313 cites W2950055141 @default.
• W3134788313 cites W2969479447 @default.
• W3134788313 doi "https://doi.org/10.1016/j.colsurfb.2021.111683" @default.
• W3134788313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33721804" @default.
• W3134788313 hasPublicationYear "2021" @default.
• W3134788313 type Work @default.
• W3134788313 sameAs 3134788313 @default.
• W3134788313 citedByCount "7" @default.
• W3134788313 countsByYear W31347883132021 @default.
• W3134788313 countsByYear W31347883132022 @default.
• W3134788313 countsByYear W31347883132023 @default.
• W3134788313 crossrefType "journal-article" @default.
• W3134788313 hasAuthorship W3134788313A5001164727 @default.
• W3134788313 hasAuthorship W3134788313A5016650663 @default.
• W3134788313 hasAuthorship W3134788313A5025782324 @default.
• W3134788313 hasAuthorship W3134788313A5032146345 @default.
• W3134788313 hasAuthorship W3134788313A5050082956 @default.
• W3134788313 hasAuthorship W3134788313A5074061540 @default.
• W3134788313 hasAuthorship W3134788313A5082976369 @default.
• W3134788313 hasAuthorship W3134788313A5085767473 @default.
• W3134788313 hasAuthorship W3134788313A5086999571 @default.
• W3134788313 hasConcept C101335993 @default.
• W3134788313 hasConcept C113196181 @default.
• W3134788313 hasConcept C120665830 @default.
• W3134788313 hasConcept C121332964 @default.
• W3134788313 hasConcept C127413603 @default.
• W3134788313 hasConcept C131888329 @default.
• W3134788313 hasConcept C13274807 @default.
• W3134788313 hasConcept C134514944 @default.
• W3134788313 hasConcept C155574463 @default.
• W3134788313 hasConcept C15920480 @default.
• W3134788313 hasConcept C159985019 @default.
• W3134788313 hasConcept C165682214 @default.
• W3134788313 hasConcept C178790620 @default.
• W3134788313 hasConcept C185592680 @default.
• W3134788313 hasConcept C191486275 @default.
• W3134788313 hasConcept C192562407 @default.
• W3134788313 hasConcept C200990466 @default.
• W3134788313 hasConcept C42360764 @default.
• W3134788313 hasConcept C43617362 @default.
• W3134788313 hasConcept C49040817 @default.
• W3134788313 hasConcept C521977710 @default.
• W3134788313 hasConcept C58226133 @default.
• W3134788313 hasConcept C77851909 @default.

• next